Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance

被引:28
|
作者
Wekerle, T
Nikolic, B
Pearson, DA
Swenson, KG
Sykes, M
机构
[1] Vienna Gen Hosp, Div Transplantat, Dept Surg, A-1090 Vienna, Austria
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, BMT Sect,Transplantat Biol Res Ctr, Boston, MA 02129 USA
关键词
tolerance; mixed chimerism; bone marrow transplantation; T cell depletion;
D O I
10.1007/s00147-002-0411-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
In a recently developed murine model for the induction of mixed chimerism and tolerance, hosts are treated with T cell depleting monoclonal antibodies (TCD mAbs; days -5, -1 and +7), thymic irradiation (TI) (7 Gy), and a high dose of fully allogeneic bone marrow cells (BMC, 200x10(6)). To find the minimum amount of each treatment required for success with this approach, we treated groups with (1) a lower dose of TI (3.5 Gy), (2) fewer BMC (100x10(6)), (3) no TI, (4) no TI plus additional TCD mAbs on day + 14, or (5) fewer injections of TCD mAbs (day -5 only). Chimerism was followed by flow cytometry (FCM), and tolerance was assessed by skin grafting. Without TI, no long-term chimerism or tolerance could be induced, even when an additional dose of TCD mAbs was administered on day +14. A reduction in the dose of either BMC or TI led to substantially reduced effectiveness, as demonstrated by lower levels of chimerism and poorer donor skin graft survival. However, the dose of TCD mAbs and hence the duration of recipient T cell depletion could be safely reduced and thus the potential toxicity of the conditioning regimen lowered.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 50 条
  • [41] CHRONIC-RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (CR-EAE) - TREATMENT AND INDUCTION OF TOLERANCE, WITH HIGH-DOSE CYCLOPHOSPHAMIDE FOLLOWED BY SYNGENEIC BONE-MARROW TRANSPLANTATION
    KARUSSIS, DM
    SLAVIN, S
    BENNUN, A
    OVADIA, H
    VOURKAKARUSSIS, U
    LEHMANN, D
    MIZRACHIKOL, R
    ABRAMSKY, O
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 39 (03) : 201 - 210
  • [42] Transplantation of autologous blood stem cells after high-dose sequential chemotherapy for lymphoma repopulates the bone marrow to a minimal proportion of the original stem cell content
    Ghielmini, M
    Marangoni, G
    Cavalli, F
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 279 - 279
  • [43] Molecular level of minimal residual disease in bone marrow before high-dose therapy and autologous stem cell transplantation is a prognostic parameter in patients with multiple myeloma
    Fenk, Roland
    Korthals, Mark
    Schnke, Nina
    Bruns, Ingmar
    Czibere, Akos
    Zohren, Fabian
    Safaian, Nancy
    Dienst, Ariane
    Ruf, Leilani
    Neumann, Frank
    Haas, Rainer
    Kronenwett, Ralf
    Kobbe, Guido
    BLOOD, 2007, 110 (11) : 448A - 448A
  • [44] Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy
    Yasuyuki Arai
    Kazunari Aoki
    June Takeda
    Tadakazu Kondo
    Tetsuya Eto
    Shuichi Ota
    Hisako Hashimoto
    Takahiro Fukuda
    Yukiyasu Ozawa
    Yoshinobu Kanda
    Chiaki Kato
    Mineo Kurokawa
    Koji Iwato
    Makoto Onizuka
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Akiyoshi Takami
    Journal of Hematology & Oncology, 8
  • [45] Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy
    Arai, Yasuyuki
    Aoki, Kazunari
    Takeda, June
    Kondo, Tadakazu
    Eto, Tetsuya
    Ota, Shuichi
    Hashimoto, Hisako
    Fukuda, Takahiro
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Kato, Chiaki
    Kurokawa, Mineo
    Iwato, Koji
    Onizuka, Makoto
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Takami, Akiyoshi
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [46] Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation
    Takahiko Nakane
    Hirohisa Nakamae
    Hideo Koh
    Mika Nakamae
    Yoshiki Hayashi
    Mitsutaka Nishimoto
    Takuro Yoshimura
    Eri Inoue
    Atsushi Inoue
    Ran Aimoto
    Mizuki Aimoto
    Yoshiki Terada
    Ki-Ryang Koh
    Takahisa Yamane
    Masayuki Hino
    International Journal of Hematology, 2011, 93 : 509 - 516
  • [47] Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children
    Nagatoshi, Y
    Okamura, J
    Ikuno, Y
    Akamatsu, M
    Tasaka, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 65 (03) : 269 - 275
  • [48] Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation
    Nakane, Takahiko
    Nakamae, Hirohisa
    Koh, Hideo
    Nakamae, Mika
    Hayashi, Yoshiki
    Nishimoto, Mitsutaka
    Yoshimura, Takuro
    Inoue, Eri
    Inoue, Atsushi
    Aimoto, Ran
    Aimoto, Mizuki
    Terada, Yoshiki
    Koh, Ki-Ryang
    Yamane, Takahisa
    Hino, Masayuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (04) : 509 - 516
  • [49] The Level of Minimal Residual Disease in the Bone Marrow of Patients with Multiple Myeloma before High-Dose Therapy and Autologous Blood Stem Cell Transplantation Is an Independent Predictive Parameter
    Korthals, Mark
    Sehnke, Nina
    Kronenwett, Ralf
    Bruns, Ingmar
    Mau, Jochen
    Zohren, Fabian
    Haas, Rainer
    Kobbe, Guido
    Fenk, Roland
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) : 423 - 431
  • [50] Non-myeloablative bone marrow transplantation with T-cell costimulation blockade produces high level mixed-chimerism in non-human primates.
    Kean, L
    Adams, A
    Hendrix, R
    Jiang, J
    Cardona, K
    Milas, Z
    Strobert, E
    Pearson, T
    Larsen, C
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 94 - 94